Spironolactone Suspension not checked
FollowEvery change as it happens, and a Monday email
Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- Blocks aldosterone, a hormone that makes the body hold on to salt and water and can scar the heart and kidneys.Aldosterone Antagonist FDA class
- How it’s given
- “Spironolactone will be dosed on a mg/kg basis, with actual weight on Day 1 (pre-dose) determining the spironolactone suspension volume administered. Therefore, for a given patient, the dose administered on Day 1, based on the weight measured on Day 1, will be administered throughout their participation in the study. Spironolactone will be administered as a single dose in the single-dose periods…”In the company’s words, NCT06021860 on ClinicalTrials.gov
- Tested for
- Edema Due to Heart Failure or Cirrhosis
- Main trialPhase 4
- “This is a 2-part, 2 periods per part, open-label study with spironolactone oral suspension in pediatric patients with edema due to HF or hepatic cirrhosis. Both study parts will evaluate the safety, PK and PD of multiple doses of spironolactone in patients aged from birth to ≤17 years of age.”In the company’s words, NCT06021860 on ClinicalTrials.gov
- Other names
- Carospir
Other drugs for Edema Due to Heart Failure or Cirrhosis
- ElafibranorIpsen · Phase 3
- MosliciguatPulmovant, Inc. · Phase 3
- ResmetiromMadrigal Pharmaceuticals · Phase 3
- SC1011JOYO Pharma · Phase 2/3
- Saroglitazar MagnesiumZydus Therapeutics Inc. · Phase 3
- NerandomilastBoehringer Ingelheim · Phase 3
Coming up1
- Jun 2028Phase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Not yet recruiting | Jun 2028 | A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026